MAXONA Pharmaceuticals Employee Directory
Pharmaceutical ManufacturingPennsylvania, United States2-10 Employees
MAXONA Pharmaceuticals operates as a clinical-stage pharmaceutical company focused on advancing new therapies for pain management. Based in Malvern, Pennsylvania, and supported by a small team, it is developing an oral therapy with a non-opioid, non-NSAID profile and a novel mechanism of action intended for both acute and chronic pain. Its lead candidate, MAX-001, is a patent-protected, optimized formulation of nefopam, which is widely used outside the United States to treat acute and chronic pain, with development initially focused in the United States. The company aims to address the unmet need for effective pain treatments that avoid the side effects and addiction risks associated with NSAIDs and opioids. A leadership team with extensive experience across development and commercialization supports the effort. In August 2025, MAXONA announced a collaboration with Ardena for the MAX-001 program, signaling a strategic partnership to advance development.